A medical epidemiologist explains who should consider getting a booster and whether you might need to check your antibody levels.

Syngene International Limited, today announced the conclusion of the acquisition of its first biologics site in the USA, ...

We recently shared a list of 10 Best Short Squeeze Stocks To Buy According to Analysts. In this article, we will see how TG ...

Get the best of the Pacific in your inbox!

HUTCHMED provides full year 2025 guidance for Oncology/Immunology consolidated revenue of $350 million to $450 million. HUTCHMED's work in 2025 and beyond will be supported by its strong balance sheet ...